绥美凯多少钱

In January 2018, Inbec, an innovative AIDS treatment drug from ViiV Healthcare, a joint venture of the British multinational pharmaceutical company GlaxoSmithKline (GSK), officially launched in the Chinese market. Trimax Inbec is the only three-in-one compound drug containing dolutegravir (DTG), which integrates treatment drugs for different stages of viral infection in the same tablet. Patients only need to take one drug to achieve the effect of combined medication.

Suimeikai Inbec has the characteristics of good efficacy and few side effects in treating HIV. Its common side effects include: nausea/insomnia/dizziness/headache, etc. Patients with abacavir hypersensitivity often experience nausea/vomiting/diarrhoea/fever/drowsiness/rash and other symptoms while using Suimeiqi Inbec. Patients who are allergic to any of the ingredients in Doptabalamid Tablets (Simeika) should not use this drug for treatment. Before receiving treatment with Suimeikan Inbec, patients should go to the hospital for a detailed examination and take medication according to the doctor's diagnosis and treatment recommendations.

  In order to reduce the impact of side effects on patients, the correct usage and dosage should be followed during the treatment of Trimax Inbec. Trimax is a fixed-dose tablet and cannot be used for patients who need dose adjustment. If the patient has special circumstances, he or she needs to change the use of other drugs according to the actual situation by an experienced doctor.

The original drug of Suimeike Inbec is relatively expensive, which is a big burden for patients who need to take the drug for a long time for treatment. Therefore, many patients choose the Indian version of Suimeike. Due to patent protection restrictions, many drugs are prohibited from being copied in most countries around the world. However, due to the protection of India's special patent laws, Indian Emcure Pharmaceuticals can produce drugs that are almost as effective as the original drugs and have high cost performance.

How much does Suimeikat cost from India's Emcure Pharmaceuticals?

It is understood that the specifications produced by Emcure Pharmaceuticals in India are 30 tablets per box, and the price is around $900. Due to the floating exchange rate, the price is not fixed. If patients want to know the specific price information of Suimeikai, they can consult the medical companion travel service.

Recommended related hot articles: /newsDetail/87219.html